Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Critical Reviews in Oncology/Hematology|May 24, 2020
Early ageing after cytotoxic treatment for testicular cancer and cellular senescence: Time to actSjoukje Lubberts, Coby Meijer, Marco Demaria, et al.
Biochemical Pharmacology|April 24, 2016
The endoplasmic reticulum stress/unfolded protein response in gliomagenesis, tumor progression and as a therapeutic target in glioblastomaNatalia M Peñaranda Fajardo, Coby Meijer, Frank A E Kruyt
Pharmacological Research|December 3, 2005
A review on pro- and anti-angiogenic factors as targets of clinical interventionDiane Bouïs, Yoka Kusumanto, Coby Meijer, et al.
Anticancer Research|April 12, 2003
CDT6-expression can alter tumor sensitivity to chemotherapyDiane Bouïs, Geke A P Hospers, Coby Meijer, et al.
Oncology Reports|December 4, 2009
Vascular damage in testicular cancer patients: a study on endothelial activation by bleomycin and cisplatin in vitroJanine Nuver, Esther C De Haas, Martine Van Zweeden, et al.
Vaccine|November 3, 2009
Construction of a triple modified p53 containing DNA vaccine to enhance processing and presentation of the p53 antigenGeke A P Hospers, Coby Meijer, Wendy A Dam, et al.
Drug Target Insights|September 9, 2011
Circulating vascular endothelial growth factor (VEGF) levels in advanced stage cancer patients compared to normal controls and diabetes mellitus patients with critical ischemiaYoka H Kusumanto, Coby Meijer, Wendy Dam, et al.
Angiogenesis|May 29, 2004
Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factorYoka H Kusumanto, Wendy A Dam, Geke A P Hospers, et al.
In Vivo (Athens, Greece)|June 10, 2003
Effects of the CDT6/ANGX gene on tumour growth in immune competent miceDiane Bouïs, Geke A P Hospers, Coby Meijer, et al.
Biochemical Pharmacology|July 3, 2002
JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatinEelco Fokkema, Harry J M Groen, Marco N Helder, et al.
Pageof 5